Eprazole enteric-coated tablets work to treat duodenal ulcers and reflux esophagitis. The drug is an irreversible proton pump inhibitor, which selectively enters the cells of the gastric wall after oral administration and is converted into the active metabolite of hyposulfonamide, which produces the effect of inhibiting the secretion of gastric acid. Therefore, the drug is clinically used in the treatment of duodenal ulcer and reflux esophagitis. During the use of the drug there are adverse reactions such as headache, dizziness, gastrointestinal discomfort, rash. It is contraindicated for those who are allergic to any of the components of the product, for those who are allergic to eplazole and other benzimidazole compounds, for infants and young children. The drug cannot be chewed or crushed, and should be swallowed whole; for general peptic ulcer and other diseases, it is not advisable to take large doses for a long period of time; blood magnesium levels should be monitored regularly during the use of the drug to prevent hypomagnesemia; caution should be exercised in patients with hepatic or renal insufficiency, pregnant women and breastfeeding women. If you need to use the drug, should be used under the guidance of a specialist physician, not self-medication, in order to avoid adverse reactions.